当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 资产负债表

华海药业

(600521)

  

流通市值:241.06亿  总市值:241.06亿
流通股本:14.97亿   总股本:14.97亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金1,897,240,615.061,504,291,385.011,420,023,169.521,635,825,564.7
  交易性金融资产77,471,707.2375,981,438.9692,218,690.2675,581,068.38
  应收票据及应收账款2,719,801,359.742,867,724,799.292,820,719,979.353,167,746,725.02
        应收账款2,719,801,359.742,867,724,799.292,820,719,979.353,167,746,725.02
  应收款项融资315,446,420.62304,505,039.62189,502,614.94154,015,335.06
  预付款项84,260,007.8276,422,532.9697,459,190.0193,692,539.36
  其他应收款合计325,686,759.4440,041,383.4132,501,910.6129,307,639.6
  存货3,645,986,136.83,712,409,370.543,813,635,900.313,592,725,898.89
  其他流动资产152,951,176.81160,897,926.3181,889,392.31150,215,457.72
  流动资产合计9,218,844,183.528,742,273,876.098,647,950,847.318,899,110,228.73
非流动资产:
  长期股权投资511,142,989.1373,386,244.11368,123,070.6411,118,353.91
  其他权益工具投资35,149.4635,149.4635,149.4635,149.46
  其他非流动金融资产399,922,381.93396,637,511.7390,002,469.72422,481,990.56
  投资性房地产867,914.77877,854.73887,794.69897,734.65
  固定资产7,363,678,583.417,380,372,221.987,036,723,852.586,839,873,241.52
  在建工程2,160,862,231.631,987,104,097.652,109,725,463.692,101,657,341.16
  使用权资产42,691,502.88105,015,121104,590,928.14119,323,509.95
  无形资产1,140,318,174.821,158,411,475.211,183,002,080.771,196,765,310.09
  开发支出1,087,989,503.231,063,123,404.341,029,775,160.98986,984,260.09
  商誉64,445,908.0664,445,908.0664,445,908.0664,445,908.06
  长期待摊费用31,838,640.134,445,072.7933,021,788.4135,349,352.48
  递延所得税资产192,090,689.24194,778,922.56183,694,795.13187,754,690.42
  其他非流动资产1,517,628.052,056,919.7712,285.86101,398.4
  非流动资产合计12,997,401,296.6812,760,689,903.2912,504,740,748.0912,366,788,240.75
  资产总计22,216,245,480.221,502,963,779.3821,152,691,595.421,265,898,469.48
流动负债:
  短期借款3,109,981,937.872,860,322,221.062,603,028,174.572,046,137,446.69
  应付票据及应付账款1,617,442,042.921,806,914,403.691,684,883,190.621,638,551,016.48
  其中:应付票据537,711,955.93626,645,387.55577,906,671.24510,779,569.99
        应付账款1,079,730,086.991,180,269,016.141,106,976,519.381,127,771,446.49
  合同负债38,439,663.2234,987,956.3234,640,027.1646,893,468.24
  应付职工薪酬182,333,912.44340,639,000.63205,616,554.92186,270,878.74
  应交税费102,448,783.37126,388,246.9397,770,873.5373,006,880.65
  其他应付款合计754,589,620.59679,281,319.77783,861,208.99836,529,681.29
  一年内到期的非流动负债3,297,384,922.673,260,748,221.541,121,632,376.03867,657,267.29
  其他流动负债2,098,944.93,102,061.992,681,184.744,354,815.94
  流动负债合计9,104,719,827.989,112,383,431.936,534,113,590.565,699,401,455.32
非流动负债:
  长期借款2,238,012,5001,841,052,5001,954,375,0002,518,092,895
  应付债券--1,953,374,101.231,929,375,392.98
  租赁负债24,686,026.5575,635,798.7274,004,209.9486,677,891.27
  长期应付款211,835,616.46209,369,863.03206,849,315.08204,328,767.13
  预计负债131,961,653.8139,644,169.94141,819,596.86147,217,214.43
  递延收益643,518,072.69661,835,092.13684,793,029.32671,895,588.92
  其他非流动负债7,006,261.497,006,261.493,777,7503,777,750
  非流动负债合计3,257,020,130.992,934,543,685.315,018,993,002.435,561,365,499.73
  负债合计12,361,739,958.9712,046,927,117.2411,553,106,592.9911,260,766,955.05
所有者权益(或股东权益):
  实收资本(或股本)1,497,252,1361,497,252,1361,497,251,4421,497,251,081
  其他权益工具240,129,874.34240,129,874.34240,132,872.08240,134,436.12
  资本公积1,612,133,180.651,610,398,175.981,559,527,174.361,555,301,603.72
  减:库存股100,005,113.91100,005,113.91100,005,113.91100,005,113.91
  其他综合收益-4,833,525.67-3,158,793.08726,231.073,599,066.16
  专项储备3,239,961.63,200,382.323,316,969.253,354,907.93
  盈余公积752,684,367.04752,684,367.04745,795,769.54745,795,769.54
  未分配利润5,846,358,3515,442,182,781.185,563,180,324.725,964,868,473.87
  归属于母公司股东权益合计9,846,959,231.059,442,683,809.879,509,925,669.119,910,300,224.43
  少数股东权益7,546,290.1813,352,852.2789,659,333.394,831,290
  股东权益合计9,854,505,521.239,456,036,662.149,599,585,002.4110,005,131,514.43
  负债和股东权益合计22,216,245,480.221,502,963,779.3821,152,691,595.421,265,898,469.48
公告日期2026-04-302026-04-302025-10-312025-08-26
审计意见(境内)标准无保留意见
TOP↑